Estados Unidos · Plataformas y datos · TradingView

IDEXX Laboratories Q3 Revenue Rises 10%; Comparable EPS Reaches $3.96

Publicado por TradingView · Estados Unidos hace 1 d

IDEXX Laboratories reported third-quarter 2026 revenue of $1.214 billion, up 10% year over year, and diluted EPS of $4.01. Comparable diluted EPS was $3.96, a 22% increase. The…

Leer el artículo completo en TradingView Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.tradingview.com)

IDEXX Laboratories Q3 Revenue Rises 10%; Comparable EPS Reaches $3.96

También te puede interesar

Metallus Non-GAAP EPS of $0.35 beats by $0.06, revenue of $337.2M misses by $6.8M

NAPCO Security Technologies, Inc. (NASDAQ:NSSC) Shareholders to Collect $0.17 Quarterly Dividend

Ichor's Profit Jumps as Cash Burn Grows: Rapid Earnings Reaction

Wall Street’s most hated stocks are faring far better than its favorites

Texas governor race tightens in prediction markets, but Abbott remains favored

Chemours stock up 2% on outlook despite Q3 miss

IDEXX Laboratories Q3 Revenue Rises 10%; Comparable EPS Reaches $3.96

Compartir

También te puede interesar

Metallus Non-GAAP EPS of $0.35 beats by $0.06, revenue of $337.2M misses by $6.8M

NAPCO Security Technologies, Inc. (NASDAQ:NSSC) Shareholders to Collect $0.17 Quarterly Dividend

Ichor's Profit Jumps as Cash Burn Grows: Rapid Earnings Reaction

Wall Street’s most hated stocks are faring far better than its favorites

Texas governor race tightens in prediction markets, but Abbott remains favored

Chemours stock up 2% on outlook despite Q3 miss